CCHT(SZ:000661) Zheng Quan Ri Bao·2025-10-31 08:40Core Insights - Changchun Gaoxin announced that its product Jinbeixin is expected to be approved by the end of June 2025 and will start sales in mid-July 2025, with good sales performance already reported [2] - The company has established a sales team of over 200 people and is rapidly increasing its coverage in hospitals and channels [2] - The product Meishiya, targeting cancer-related anorexia-cachexia syndrome, has generated nearly 100 million yuan in sales revenue in the first three quarters of this year [2] - The company plans to actively promote its products in conjunction with national medical insurance negotiations to enhance recognition and acceptance among hospitals, doctors, and patients [2] - The company aims to focus resources on new products with high market potential to drive new business growth and support its diversification and transformation efforts [2]